LEADER 02369oam  2200541 a 450 
001 9910695372903321
005 20060925141919.0
035   $a(CKB)5470000002369019
035   $a(OCoLC)70119644
035   $a(EXLCZ)995470000002369019
100   $a20060306d2006      ua         0
101 0 $aeng
135   $aurcn|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for medical screening of commercial aerospace passengers $efinal report /$fMelchor J. Antun?ano ... [and others]
210  1$aWashington, D.C. :$cU.S. Dept. of Transportation, Federal Aviation Administration, Office of Aerospace Medicine ;$aFt. Belvoir, VA :$cAvailable to the public through the Defense Technical Information Center ;$aSpringfield, Va. :$cAvailable to the public through the National Technical Information Service,$d[2006]
215   $ai, 3, 1, 2 pages $cdigital, PDF file
300   $aTitle from PDF cover (viewed on June 7, 2006).
300   $a"DOT/FAA/AM-06/1."
300   $a"January 2006."
300   $aPerformed by the FAA Civil Aerospace Medical Institute, Oklahoma City, OK.
330 3 $aThis document provides general guidance for operators of manned commercial aerospace flights (suborbital and orbital) in the medical assessment of prospective passengers.
517   $aGuidance for medical screening of commercial aerospace passengers 
606   $aAeronautics, Commercial$xPassenger traffic
606   $aSpace flight$xPhysiological effect
606   $aDiagnostic Techniques and Procedures$xstandards
606   $aSpace Flight
606   $aCommerce
607   $aUnited States
608   $aGuideline.
615  0$aAeronautics, Commercial$xPassenger traffic.
615  0$aSpace flight$xPhysiological effect.
615 12$aDiagnostic Techniques and Procedures$xstandards.
615 12$aSpace Flight.
615 22$aCommerce.
701   $aAntun?ano$b Melchor J$01381113
712 02$aUnited States.$bOffice of Aerospace Medicine.
712 02$aUnited States.$bFederal Aviation Administration.
712 02$aCivil Aerospace Medical Institute.
801  0$bNLM
801  1$bNLM
801  2$bGPO
906   $aBOOK
912   $a9910695372903321
996   $aGuidance for medical screening of commercial aerospace passengers$93423456
997   $aUNINA